Aliceweissfeld_cv

microbiology specialists inc.
Curriculum Vitae
Alice Schauer Weissfeld, PhD, D (ABMM)
Position
President and CEO Microbiology Specialists Incorporated Houston, Texas Mailing Address
Microbiology Specialists Incorporated 8911 Interchange Drive Houston, Texas 77054-2507 713-663-6888 Birthplace
Birth Date
Education
B.A., Biology, Boston University, 1970 M.S., Microbiology, Rutgers University, 1972 Ph.D., Microbiology, Rutgers University, 1976 Certification
1980
Diplomate (Public Health and Medical Laboratory Microbiology), The American Board of Medical Microbiology. Licensure
1982
Clinical Microbiologist, State of California Department of Health Services (DRI19). Clinical Microbiologist Technologist, State of California Department of Health Services, (MTE454). Laboratory Director, New York State Department of Health (B5683).
Academic Appointments
1970 to 1974
National Cancer Institute Predoctoral Trainee, Department of Microbiology, College of Medicine and Dentistry of New Jersey - Rutgers Medical School, Piscataway, New Jersey. Department Research Fellow, Department of Microbiology, College of Medicine and Dentistry of New Jersey - Rutgers Medical School, Piscataway, New Jersey. Postdoctoral Fellow in Public Health and Medical Laboratory Microbiology, Department of Microbiology and Immunology, Baylor College of Medicine, Houston, Texas. Instructor, Department of Pathology, Washington University School of Medicine, St. Louis, Missouri. Alice S. Weissfeld – Page 2.
Instructor, Department of Microbiology and Immunology, Washington University School of Medicine, St. Louis, Missouri. Adjunct Assistant Professor, Department of Microbiology and Immunology, Baylor College of Medicine, Houston, Texas. 2001 to Present Adjunct Assistant Professor, Department of Molecular Virology and Microbiology, Baylor
Hospital Appointments
1978 to 1981
Associate in Microbiology, Department of Pathology and Laboratory Medicine, The Jewish Hospital of St. Louis, St. Louis, Missouri. Chief Microbiologist, Division of Clinical Pathology, Cedars-Sinai Medical Center, Los Angeles, California.
Honorific Organizations

Fellow, American Academy of Microbiology
Professional Societies
American Society for Microbiology
American Industrial Hygiene Association

National Awards

1999
ABMM Professional Recognition Award, American Society for Microbiology Outstanding Service Award, American Industrial Hygiene Association bioMérieux Sonnenwirth Award for Leadership in Clinical Microbiology, American Society for Microbiology
National and State Appointments
1985 to 1986
Member, IB Examination Committee, The American Board of Medical Microbiology. Advisor, Subcommittee on Cost-Effective Quality Control, National Committee for Clinical Laboratory Standards. Member, Part I Examination Committee, The American Board of Medical Microbiology. Member, Committee on Laboratory Practices in Microbiology, American Society for Microbiology. Special Reviewer, National Committee for Clinical Laboratory Standards. Participant, Critical Issues Workshop, Washington, D.C., American Academy of Microbiology. Member, Committee on Public and Scientific Affairs, Texas Branch, American Society for Microbiology. Member, Committee of Public Service and Adult Education, American Society for Microbiology. Alice S. Weissfeld – Page 3.
Chair, Microbiology Standards and Examination Committee, The American Board of Medical Microbiology. Chair, Committee on Public and Scientific Affairs, Texas Branch, American Society for Member, Task Group On Microbiological Analysis of Water Samples for Legionella, American Society for Testing and Materials. Foundation for Microbiology Lecturer, American Society for Microbiology. Chair, Joint Examinations Committee, The American Board of Medical Microbiology. Member, EMPAT Subcommittee of the Biosafety Committee, American Industrial Hygiene Association. Member, Bioaerosol Task Force, American Industrial Hygiene Association. Chair, Committee on Professional Affairs in Microbiology, American Society for Member, Laboratory Technical Advisory Committee, Health Care Financing Administration. Member, Environmental Microbiology Laboratory Accreditation Committee, American Industrial Hygiene Association. American Society for Microbiology Alternate, Negotiated Rulemaking on Clinical Diagnostic Laboratory Tests, Department of Health and Human Services. Vice Chair, Environmental Microbiology Laboratory Accreditation Committee, American Industrial Hygiene Association. Chair, Environmental Microbiology Laboratory Accreditation Committee, American Industrial Hygiene Association. Member, Clinical Laboratory Improvement Advisory Committee, Department of Health and Human Services, Centers for Disease Control and Prevention. Participant, American Academy of Microbiology colloquium, “Bioterrorism Threats to Our Future: The role of the clinical microbiology laboratory in detection, identification and confirmation of biological agents”, San Antonio, Texas. Past Chair, Environmental Microbiology Laboratory Accreditation Committee, American
Consultantships
1987 to 1988
Consultant, Microbiology Laboratory, National Aeronautics & Space Administration, Johnson Space Center, Houston, Texas. Consultant, Microbiology Laboratory, Bee-Mac Reference Laboratory, Houston, Texas. Consultant, Microbiology Laboratory, Medical Clinic of Houston, Houston, Texas. Alice S. Weissfeld – Page 4.
Consultant, Molecular Analysis Incorporated, Houston, Texas. Consulting Director, OB/Gyn Infectious Disease Laboratory, University of Texas Medical Branch at Galveston, Galveston, Texas. Consultant, Spring Branch Medical Center Microbiology Laboratory, Houston, Texas. Consultant, National Aeronautics & Space Administration, Johnson Space Center, Laboratory Director, Planned Parenthood of Houston and Southeast Texas, Inc.,
Editorial Services
1983 to 1999
Member, Editorial Board, Cumulative Techniques and Procedures in Clinical Microbiology (American Society for Microbiology), Washington, D. C. Associate Editor, Clinical and Pathogenic Microbiology, The C.V. Mosby Co., St. Louis, Missouri. Section Editor, Bacteriology, Manual of Clinical Microbiology, 6th edition (American Society for Microbiology), Washington, D.C. Associate Editor, Clinical and Pathogenic Microbiology, 2nd edition, The C.V. Mosby Co., St. Louis, Missouri. Chair, Editorial Board, Cumulative Techniques and Procedures in Clinical Microbiology (American Society for Microbiology), Washington, D.C.
Textbooks
Forbes, B.A., D.F. Sahm and A.S. Weissfeld. 1998. Bailey and Scott's Diagnostic Microbiology, 10th ed. C.V.
Mosby Co., St. Louis.
Forbes, B.A., D.F. Sahm and A.S. Weissfeld. 2002. Bailey and Scott’s Diagnostic Microbiology, 11th ed. C.V.
Mosby Co., St. Louis.

Abstracts
Sonnenwirth, A.C., and A.S. Weissfeld. 1981. Newer aspects of Yersinia enterocolitica enteric infections in
adults. Abstr. XI Triennial World Congress of Pathology, p. 269.
Sonnenwirth, A.C., and A.S. Weissfeld. 1982. Evaluation of a new radiometric resin containing medium for
recovery of aerobic and facultatively anaerobic organisms from blood cultures. Abstr. Ann. Meeting Am. Soc.
Microbiol., Abstr. C121, p. 291.
Lewis, R.A., A.S. Weissfeld, and M.K. White. 1984. Yersinia enterocolitica - Breaking Tradition? Abstr. Ann.
Meeting Am. Soc. Microbiol., Abstr. C79, p. 249.

Clarner, P.R., D.E. Simmons, P.H. Vance, and A.S. Weissfeld. 1992. Evaluation of a reformulated DNA probe
for Mycobacterium avium complex (Gen-Probe) and comparison to the SNAP Mycobacterium avium complex DNA
probe (Syngene). Abstr. Ann. Meeting Am. Soc. Microbiol., Abstr. C185, p.451.
Alice S. Weissfeld – Page 5.
Jenschke, W.J., E. Trevino, P.H. Vance, and A.S. Weissfeld. 1993. Comparison of direct urine and standard
Kirby Bauer sensitivities. Abstr. Ann. Meeting Am. Soc. Microbiol., Abstr. C190, p. 479.
Morey, P.R., J. Gallup, P.H. Vance, D. Walther, and A.S. Weissfeld. 1994. Air sampling for environmental
fungi: Comparison of analytical results from three independent laboratories. Abstr. Ann. Meeting American
Industrial Hygiene Conference and Exposition, Abstr. 210, p.70.
Weissfeld, A.S., D.E. Simmons, D. Busch, R.K. Flamm, S.K. Tanaka, A. Cicciola, and D. Webb. 1994. In vitro
susceptibility of pretreatment isolates of H. pylori (Hp) from a multicenter United States clinical trial. In Abstracts
of the conference Helicobacter pylori: Beginning the second decade, Houston, Texas, Abstr. 422, p. 60.
Turner, B.P., C.E. Peyton, B.T. Wisnoski, K.L. Davis, K.G. Carter, G.D. Anderson, A.S. Weissfeld, and W.S.
Riggins. 1995. The rate of coinfectivity with Neisseria gonorrhoeae from patients infected with Chlamydia
trachomatis. Abstr. Ann. Meeting. Am. Soc. Microbiol., Abstr. C126, p. 22.
Weissfeld, A.S., D.E. Simmons, P.H. Vance, E. Trevino, M. Haber, D. Jhala, J. Horton, S. Kidd, and P.
Greski-Rose. 1996. Comparison between isolation of Helicobacter pylori from gastric biopsies transported at 4°C
in Stuart's medium and histological evidence of infection. Abstr. Digestive Disease Week, Abstr. 1219, p. A-305.
Weissfeld, A.S., D.E. Simmons, P.H. Vance, E. Trevino, S. Kidd, and P. Greski-Rose. 1996. In vitro
susceptibility of pretreatment isolates of Helicobacter pylori from two multicenter United States clinical trials.
Abstr. Digestive Disease Week, Abstr. 3912, p. A978.
Vance, P.H., A.S. Weissfeld, B.J. Marino, and E. Trevino. 1997. Use of direct specimen examination to detect
parasites in bulk samples from indoor environments. Abstr. Ann. Meeting Am. Soc. Microbiol., Abstr. Q40, p. 462.
Weissfeld, A.S., P.A. Fuselier, P.H. Vance, and K. Lamprecht. 1997. Retrospective review of the suitability of
stat requests for respiratory syncytial virus (RSV) direct exams. Abstr. Thirteenth Annual Clinical Virology
Symposium, Abstr. T30.
Weissfeld, A.S., G.E. Sepulveda, P.R. Clarner, C. Melendez, P.H. Vance, V. Polonio, and O. V. Torres. 1997.
Incidence and prevalence of Mycobacterium avium complex bacteremia and pneumonia in HIV-positive patients in
Puerto Rico. Abstr. Ann. Meeting Am. Soc. Microbiol., Abstr. C453, p. 199.
Weissfeld, A.S., M. Haber, P. Rose, S. Kidd, and N. Siepman. 1997. Geographical distribution in the United
States of primary resistance to clarithromycin and metronidazole in patients infected with Helicobacter pylori.
Gastroenterology 112S:A328.
Weissfeld, A.S., D. Simmons, P. Rose, S. Kidd, N. Lukasik, and N. Siepman. 1997. Susceptibility of
Helicobacter pylori to clarithromycin and amoxicillin in U. S. Gastroenterology 112S:A329.
Weissfeld, A.S., D. Simmons, P. Rose, S. Kidd, and N. Siepman. 1997. Interpretive criteria for susceptibility
testing of clarithromycin and amoxicillin against Helicobacter pylori using the epsilometer test (E-test®).
Gastroenterology 112S:A329.
Weissfeld, A.S., S. Kidd, C. Fludas, P. Greski-Rose, N. Siepman, and B. Hunt. 1998. Comparison of agar
dilution vs. E-test® in the interpretation of antimicrobial susceptibility to H. pylori. Abstr. Digestive Disease Week,
Abstr. G1344, p. updated session insert.
Smahlik, H.J., M.M. Shelton, L.J. Carollo, J. Shelton, M. Linenberger, J. Sawyers, A.S. Weissfeld, and P.H.
Vance. 2000. The prevention of nosocomial infections in a bone marrow transplant unit during building renovations.
Abstr. CDC 4th Decennial International Conference on Nosocomial and Healthcare-associated Infections, P-TI-66, p.
193.
Alice S. Weissfeld – Page 6.

Jones, L., A.S. Weissfeld, R. Aldeen, J. Talaska, D.L. Zumerling, C. Barnes, and L. Mann. 2001. Cross testing
of patient samples collected and transported in NATTM – Nucleic Acid Transport on four nucleic acid systems for C.
trachomatis and N. gonorrhoeae. Abstr. Seventeenth Annual Clinical Virology Symposium, Abstr. S48.
Jones, L., A.S. Weissfeld, R. Aldeen, J. Talaska, D.L. Zumerling, C. Barnes, and L. Mann. 2001. NATTM –
Nucleic Acid Transport and sample stability at various temperatures. Abstr. Seventeenth Annual Clinical Virology
Symposium, Abstr. S49.
Jones, L., A.S. Weissfeld, R. Aldeen, J. Talaska, and D.L. Zumerling. 2001. Clinical patient sample results using
NATTM – Nucleic Acid Transport – A new multi-test transport for amplified and nonamplified C. trachomatis and
N. gonorrhoeae detection assays. Abstr. Seventeenth Annual Clinical Virology Symposium, Abstr. S50.
Weissfeld, A.S, D. Simmons, E. Trevino, P. Vance, D. Mandvia, M. Delaney, A. Onderdonk, and C.C. Davis.
2001. Evaluation of transport media and sampling devices for the recovery of various bacteria and yeast from
simulated and actual vaginal specimens. Abstr. Ann. Meeting Am. Soc. Microbiol., Abstr. C-54, p. 159.
Turner, B.P., A.S. Weissfeld, P.H. Vance, E. Trevino, D. Simmons, L. Jones, and A. Hightower. 2001. A
comparison of Chlamydia trachomatis culture and three molecular tests using swabs and urines. Abstr. Ann.
Meeting Am. Soc. Microbiol., Abstr. C-203, p. 197.
Martin, D.H., E.W. Hook, D. Ferrero, D. Willis, J. Schachter, A.S. Weissfeld, C. Gaydos, and T. Quinn. 2001.
Comparison of Gen-Probe APTIMA Combo 2 (AC2) Assay for C. trachomatis (CT) and N. gonorrhoeae (GC) with
LCR, PCR and GC culture on urine swab specimens from men and women. Abstr. Ann. Meeting Am. Soc.
Microbiol., Abstr. C-204, p. 197.

Smith, K., E.W. Hook, D.H. Martin, D. Willis, J. Schachter, C. Gaydos, T. Quinn, A.S. Weissfeld and D.
Ferrero. 2001. APTIMA Combo 2, a new assay for detection of Chlamydia trachomatis in men. Abstr. Ann.
Meeting Am. Soc. Microbiol., Abstr. C-205, p. 197.
Ferrero, D.V., C.A. Gaydos, T.C. Quinn, E.W. Hook, III, D.H. Martin, J. Schachter, A.S. Weissfeld, and D.
Willis. 2001. Multicenter clinical trial performance of the new Gen-Probe APTIMATM Combo 2 Assay for
detecting Chlamydia trachomatis in female endocervical and urine specimens. Abstr. Ann. Meeting Am. Soc.
Microbiol., Abstr. C-206, p. 197.
Collum, S.C., E.W. Hook, D.H. Martin, D. Willis, J. Schachter, A.S. Weissfeld, C. Gaydos, T. Quinn, and D.
Ferrero. 2001. Multi-site comparison of Gen-Probe APTIMA Combo 2 Assay with Abbott LCR and culture for
the detection of Neisseria gonorrhoeae in men. Abstr. Ann. Meeting Am. Soc. Microbiol., Abstr. C-207, p. 198.

Weissfeld, A.S., B. Turner, P.H. Vance, E. Trevino, D.E. Simmons, L. Segura-Jones, and A. Hightower. 2001.
A comparison of Neisseria gonorrhoeae culture to three molecular tests using swabs and urines. Abstr. Ann.
Meeting Am. Soc. Microbiol., Abstr. C-208, p.198.

Zumerling, D.L., J. Talaska, R. Aldeen, L. Jones, E. Trevino, A.S. Weissfeld, M.B. Baker, D. Crouse, R.
Mathieu, E. Ammons, R.A. Hubbard, and C. Sneed. 2001. Validation of NAT-A nucleic acid transport on four
commercially available nucleic acid tests for Chlamydia trachomatis and Neisseria gonorrhoeae from swab
samples. Abstr. Ann. Meeting Am. Soc. Microbiol., Abstr. C-209, p. 198.
Martin, D.H., E.W. Hook, III, D. Ferrero, D. Willis, J. Schachter, A.S. Weissfeld, C. Gaydos, and T. Quinn.
2001. Comparison of three nucleic acid amplification tests (NAATs) and N. gonorrhoeae (GC) culture for detection
of C. trachomatis (CT) and GC using a rotating standard. International J of STD and AIDS 12, Supplement 2:97.

Hook, E.W., III, D.H. Martin, D. Willis, J. Schachter, C. Gaydos, T.C. Quinn, A.S. Weissfeld, and D. Ferrero.
2001. Comparison of Gen-Probe APTIMA Combo 2 Assay with LCX and culture for the detection of Neisseria
gonorrhoeae in men. International J of STD and AIDS 12, Supplement 2:97.
Alice S. Weissfeld – Page 7.

Ferrero, D.V., C. Gaydos, T. Quinn, E. Hook, D. Martin, J. Schachter, A.S. Weissfeld, and D. Willis. 2001.
Multicenter clinical trial performance of the new Gen-Probe APTIMA Combo 2 Assay for detecting Chlamydia
trachomatis and Neisseria gonorrhoeae in female and male urine specimens. International J of STD and AIDS 12,
Supplement 2:97.
Pate, M.S., E.W. Hook, III, D.H. Martin, D. Willis, J. Schachter, C. Gaydos, T.C. Quinn, A.S. Weissfeld, and
D. Ferrero. 2001. Gen-Probe APTIMA Combo 2: a new assay for detection of C. trachomatis in men.
International J of STD and AIDS 12, Supplement 2:116.
Turner, B., A.S. Weissfeld, P.H. Vance, E. Trevino, D.E. Simmons, and A. Hightower. 2001. Comparison of
the Gen-Probe APTIMA Combo 2 Assay with chlamydial culture, and the PCR and LCR diagnostic tests.
International J of STD and AIDS 12, Supplement 2:116.

Weissfeld, A.S., D.E. Simmons, D. Mandvia, E. Trevino, K.A. Ault and C.C. Davis. 2002. Development of an
in vitro vaginal microflora assay to evaluate safety of tampons. Obstetrics and Gynecology 99: Supplement 1, S40.
Simmons, D.E., C. Pearce, E. Trevino, S.E. Shehin, C.C. Davis, M. Jones and A.S. Weissfeld. 2003.
Development of an in vitro vaginal microflora assay to evaluate the antimicrobial effects on douche solutions
Abstr. Ann. Meeting Am. Soc. Microbial., Abstr I-078, p. 343.
A. S. Weissfeld, E. Trevino, D. Mandvia, and P. Vance. 2004 Development of a quantitative culture assay to
access the suitability of new viral transport media. Abstr. Ann. Meeting Am. Soc. Microbiol., Abstr. C-253, ASM
General Meeting, p. 158.
E. W. Hook, III, P. Fine, M. Cohen, A. Weissfeld, D. Willis, Y. Wang, and B. Fujikawa. 2004. The TIGRIS®
DTS™ System reduces operator - related error during nucleic acid amplification testing. Abstr. Ann. Meeting Am.
Soc. Microbiol., Abstr. C-280, p. 159.
Weissfeld, A. S., D. Mandvia, E. Trevino, and P. H. Vance. 2005. Use of a novel quantitative assay to compare
the viability of herpes virus in a new viral transporter with that of an existing commercial system. Abstr. Twenty-
first Annual Clinical Virology Symposium, Abstr. TA1.
Weissfeld, A. S., D. Mandvia, E. Trevino, and P. H. Vance. 2005. Quantitative study of the ability of Copan
UTM-RT™ and Remel Micro Test™ M4 specimen transporters to maintain viability of clinically important viruses,
chlamydia, mycoplasma and ureaplasma. Abstr. Ann. Meeting Am. Soc. Microbiol., Abstr. C-303.
P. Zaslavskaya, A. Weissfeld, D. F. Moore, D. Mandvia, P. Vance, J. Guzman, V. Jonas. 2006. Description of
a research TMA TB assay including internal control. Abstr. Ann. Meeting Am. Soc. Microbiol, Abstr. C-327.
Publications
Weissfeld, A.S., and H. Rouse. 1977. Arginine deprivation in KB cells. I. Effect on cell cycle progress. J. Cell Biol.
75:881-888.
Weissfeld, A.S., and H. Rouse. 1977. Arginine deprivation in KB cells. II. Characterization of the DNA
synthesized during starvation. J. Cell Biol. 75:889-898.
Weissfeld, A.S., and H. Rouse. 1977. Continued initiation of DNA synthesis in arginine-deprived Chinese hamster
ovary cells. J. Cell Biol. 73:200-205.
Weissfeld, A.S., G.D. Sanner, J.R. Childress, J.D. Dyckman, T.W. Huber and R.P. Williams. 1977. Feasibility
of screening for penicillinase-producing Neisseria gonorrhoeae from primary culture plates using a rapid
microacidometric test. Antimicrob. Agents Chemother. 12:703-706.
Alice S. Weissfeld – Page 8.
Wallace, R.J., P.H. Vance, A.S. Weissfeld, and R.R. Martin. 1978. Beta-lactamase production and resistance to
beta-lactam antibiotics in Nocardia. Antimicrob. Agents Chemother. 14:704-709.

Gronemeyer, P.A., A.S. Weissfeld, and A.C. Sonnenwirth. 1980. Corynebacterium group JK bacterial infection
in a patient with an epicardial pacemaker. Am. J. Clin. Pathol. 74:838-842.

Sack, R.B., R.C. Tilton and A.S. Weissfeld. 1980. Cumitech 12, Laboratory diagnosis of bacterial diarrhea.
Coordinating ed., S. J. Rubin. ASM Press, Washington, D.C.

Weissfeld, A.S. 1980. Nosocomial infections and hospital epidemiology (Chapter 88). In A. C. Sonnenwirth and L.
Jarrett (ed.): Gradwohl's Clinical Laboratory Methods and Diagnosis, 8th ed. The C.V. Mosby Co., St. Louis.
Weissfeld, A.S. and A.C. Sonnenwirth. 1980. Yersinia enterocolitica in adults with gastrointestinal disturbances:
need for cold enrichment. J. Clin. Microbiol. 11:196-197.

Weissfeld, A. S. 1981. Yersinia enterocolitica. Clin. Micro. Newsletter 3:91-93.
Weissfeld, A.S. and A.C. Sonnenwirth. 1981. Rapid detection and identification of Bacteroides fragilis and B.
melaninogenicus by immunofluorescence. J. Clin. Microbiol. 13:798-800.
Weissfeld, A.S. and A.C. Sonnenwirth. 1981. Yersinia - a Canadian organism? J. Pediatr. 98:504-505.
Gronemeyer, P.S., A.S. Weissfeld, and A.C. Sonnenwirth. 1982. Purulent pericarditis complicating systemic
infection with Candida tropicalis. Am. J. Clin. Pathol. 77:471-475.
Weissfeld, A.S., W. Gehle and A.C. Sonnenwirth. 1982. Comparison of several test systems used for
determination of rubella immune status. J. Clin. Microbiol. 16:82-85.
Weissfeld, A.S. and A.C. Sonnenwirth. 1982. New latex agglutination test assay for rapid determination of rubella
immune status. J. Clin. Microbiol. 16:971-972.
Weissfeld, A.S. and A.C. Sonnenwirth. 1982. Rapid isolation of Yersinia spp. from feces. J. Clin. Microbiol.
15:508-510.
Weissfeld, A.S. 1983. Genital mycoplasma. Clin. Micro. Newsletter 5:65-67.
Clarridge, J.E. and A.S. Weissfeld. 1984. Aerobic asporogenous gram-positive bacilli. Clin. Microbiol. Newsl.
6:115-118.
Ferguson, R.W. and A.S. Weissfeld. 1984. Comparison of the suitability of three common bacterial media for
susceptibility testing of trimethoprim-sulfamethoxazole. J. Clin. Microbiol. 19:85-86.
Toma, S., G. Wauters, H.M. McClure, G.K. Morris, and A.S. Weissfeld. 1984. 0:13a, 13b, a new pathogenic
serotype of Yersinia enterocolitica. J. Clin. Microbiol. 20:843-845.
Clarridge, J.E. and A.S. Weissfeld. 1985. Listeria monocytogenes. Clin. Microbiol. Newsl. 7:59-62.

Riedinger, M. S., F. G. Shellock, P. K. Shah, A. S. Weissfeld, and A. G. Ellrodt. 1985. Sterility of prefilled
thermodilution cardiac output syringes maintained at room and ice temperatures. Heart Lung 14: 8-11.
Clarridge, J.E., M.T. Pezzlo, and K. L. Vosti. 1987. Cumitech 2A, Laboratory diagnosis of urinary tract
infections. Coordinating ed., A.S. Weissfeld. ASM Press, Washington, D.C.
Clarridge, J.E. and A.S. Weissfeld. 1987. Corynebacterial infections (Chapter 13). In B. B. Wentworth (ed.):
Diagnostic procedures for bacterial infections. 7th ed., American Public Health Association, Washington, D.C.
Alice S. Weissfeld – Page 9.

Farmer III, J.J., B.J. Howard, and A.S. Weissfeld. 1987. Enterobacteriaceae (Chapter 16). In B.J. Howard, J.
Klaas II, A.S. Weissfeld, and R.C. Tilton (eds.): Clinical and Pathogenic Microbiology, The C.V. Mosby Co., St.
Louis.
Pasculle, A.W. and A.S. Weissfeld. 1987. Legionella (Chapter 24). In B.J. Howard, J. Klaas II, A.S. Weissfeld, and
R.C. Tilton (eds.): Clinical and Pathogenic Microbiology, The C.V. Mosby Co., St. Louis.
Weissfeld, A.S. and R.C. Bartlett. 1987. Quality control (Chapter 3). In B.J. Howard, J. Klaas II, A.S. Weissfeld,
and R.C. Tilton (eds.): Clinical and Pathogenic Microbiology, The C.V. Mosby Co., St. Louis.
Weissfeld, A.S., B.J. Howard, R.D. Almazan, and J.F. Keiser. 1987. Miscellaneous pathogenic organisms
(Chapter 25). In B.J. Howard, J. Klaas II, A.S. Weissfeld, and R.C. Tilton (ed.): Clinical and Pathogenic
Microbiology, The C.V. Mosby Co., St. Louis.
Weissfeld, A.S. and R.L. Kaplan. 1987. Campylobacter (Chapter 23). In B.J. Howard, J. Klaas II, A.S. Weissfeld,
and R.C. Tilton (ed.): Clinical and Pathogenic Microbiology, The C.V. Mosby Co., St. Louis.
Weissfeld, A.S. and S. Zighelboim-Daum. 1987. Clinical syndromes and diseases of interest to clinical
microbiologists (Chapter 10). In B.J. Howard, J. Klaas II, A.S. Weissfeld, and R.C. Tilton (ed.): Clinical and
Pathogenic Microbiology. The C.V. Mosby Co., St. Louis.
August, M.J., J.A. Hindler, T.W. Huber, and D.L. Sewell. 1990. Cumitech 3A, Quality control and quality
assurance practices in clinical microbiology. Coordinating ed., A.S. Weissfeld. ASM Press, Washington, D.C.
Weissfeld, A.S. 1991. Regulators and inspectors of concern to clinical microbiologists. Clin Micro. Newsletter
12:125-126.
Weissfeld, A.S. 1993. StateNet and the legislative process. Clin. Micro. Newsletter. 15:143-144.
Cernoch, P.L., R.K. Enns, M.A. Saubolle, and R.J. Wallace, Jr. 1994. Cumitech 16A, Laboratory diagnosis of
the mycobacterioses. Coordinating ed., A. S. Weissfeld. ASM Press, Washington, D. C.
Kaplan, R.L. and A.S. Weissfeld. 1994. Campylobacter, Helicobacter, and related organisms (Chapter 23). In B.J.
Howard, J.F. Keiser, T.F. Smith, A.S. Weissfeld, and R.C. Tilton (eds.). Clinical and Pathogenic Microbiology, 2nd
ed. The C. V. Mosby Co., St. Louis.
Weissfeld, A.S. and R.C. Bartlett. 1994. Quality management (Chapter 4). In B. J. Howard, J. F. Keiser, T. F.
Smith, A. S. Weissfeld, and R. C. Tilton (ed.). Clinical and Pathogenic Microbiology, 2nd ed. The C. V. Mosby Co.,
St. Louis.
Weissfeld, A.S., A.M. McNamara, R.D. Almazan, and P.L. McEvoy. 1994. Miscellaneous pathogenic organisms
(Chapter 25). In B.J. Howard, J.F. Keiser, T.F. Smith, A.S. Weissfeld, and R.C. Tilton (eds.). Clinical and
Pathogenic Microbiology, 2nd ed. The C.V. Mosby Co., St. Louis.
Weissfeld, A.S., A.M. McNamara, V.L. Tesh, and B.J. Howard. 1994. Enterobacteriaceae (Chapter 16). In B.J.
Howard, J.F. Keiser, T.F. Smith, A.S. Weissfeld, and R.C. Tilton (eds.). Clinical and Pathogenic Microbiology, 2nd
ed. The C.V. Mosby Co., St. Louis.
Baron, E.J., A.S. Weissfeld, P.A. Fuselier, and D.J. Brenner. 1995. Classification and identification of bacteria
(Chapter 20). In P.R. Murray, E.J. Baron, M.A. Pfaller, F.C. Tenover, and R.H. Yolken (ed.), Manual of Clinical
Microbiology, 6th ed. ASM Press, Washington, D. C.
Alice S. Weissfeld – Page 10.

Harford, W., F. Lanza, A. Arora, D. Graham, M. Haber, A.S. Weissfeld, P. Rose, and N. Siepman. 1996.
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter
pylori infection. Helicobacter 1:243-250.
Riff, D. S., S. Kidd, P. Rose, M. Haber, A.S. Weissfeld, and N. Siepman. 1996. Triple therapy with lansoprazole,
clarithromycin, and amoxicillin for the cure of Helicobacter pylori infection: A short report. Helicobacter 1:238-
242.
Schwartz, H., R. Krause, N. Siepman, M. Haber, A.S. Weissfeld, S. Kidd, P. Rose, and B. Sahba. 1996. Seven-
day triple therapy with lansoprazole, clarithromycin and metronidazole for the cure of Helicobacter pylori infection:
A short report. Helicobacter 1:251-255.
Steingrimsson, O., C. Pawlak, B. Van Der Pol, B. P. Turner, O. J. Hjaltalin, L. Dolphin, J. E.Williams, C. E.
Peyton, R. E. Klepper, R. B. Jones, G. D. Anderson, N. Rashti, A. S. Weissfeld, and A. Pronovost. 1997.
Multicenter comparative evaluation of two rapid immunoassay methods for the detection of Chlamydia trachomatis
in endocervical specimens. Clin. Microbiol. Infect. 3:663-667.
Weissfeld, A.S. 1998. Supplementing Your Income: Alternative pathways for clinical microbiology laboratories.
Clinical Microbiology Newsletter 20: 14-15.
Clarridge, J.E., J.R. Johnson, and M.T. Pezzlo. 1998. Cumitech 2B, Laboratory diagnosis of urinary tract
infections. Coordinating ed., A.S. Weissfeld. ASM Press, Washington, D.C.
Fennerty, M.B., T.O. Kovacs, R. Krause, M. Haber, A. Weissfeld, N. Siepman and P. Rose. 1998. A
comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori. Arch. Intern.
Med. 158: 1651-6
Schwartz, H., R. Krause, B. Sahba, M. Haber, A. Weissfeld, P. Rose, N. Siepman, and J. Freston. 1998. Triple
versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind,
multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. Am. J.
Gastroenterol. 93: 584-90.
Gilchrist, M.J.R., W.P. McKinney, J.M. Miller, and A.S. Weissfeld. 2000. Cumitech 33, Laboratory safety,
management and diagnosis of biological agents associated with bioterrorism. Coordinating ed., J.W. Snyder. ASM
Press, Washington, DC.
Liu, X., B. P. Turner, C. E. Peyton, B. S. Reisner, A. O. Okorodudu, A. A. Mohammad, G. D. Hankins, A. S.
Weissfeld, and J. R. Petersen. 2000. Prospective study of IgM to Toxoplasma gondii on Beckman Coulter’s
Access™ immunoassay system and comparison with Zeus ELISA and Gull IFA assays. Diagn. Microbiol. Infect.
Dis. 36:237-9.
Baselski, V., L. Garcia, and A.S. Weissfeld. 2001. The ABCs of CPT Coding in Microbiology. Clin. Microbiol.
Newsletter 23:37-42.
Weissfeld, A.S. 2002. CPT codes and reimbursement. Pan American Society for Clinical Virology 29: 1-2.

Gaydos, C.A., T.C. Quinn, D. Willis, A. S. Weissfeld, E.W. Hook, D.H. Martin, D.V. Ferrero, and J.
Schachter. 2003. Performance of the APTIMA combo 2 assay for detection of Chlamydia trachomatis and
Neisseria gonorrhoeae in female urine and endocervical swab specimens. J. Clin. Microbiol. 41: 304-309.
Snyder, J.W. and A.S. Weissfeld. 2003. Laboratory detection of potential agents of bioterrorism (Chapter 10). In:
P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller and R. H. Yolken (ed.), Manual of Clinical Microbiology,
8th ed. ASM Press, Washington, DC.
Alice S. Weissfeld – Page 11.
Baselski, V.S., A.S. Weissfeld, and F. Sorrell. 2004. Correct coding of billable services in the clinical laboratory,
pp. 557 -566. In: Garcia, L.S., V. S. Baselski, M. D. Burke, D. A. Schwab, D. L. Sewell, J. C. H. Steele, Jr., A. S.
Weissfeld, D. S. Wilkinson, and W. C. Winn, Jr. Clinical Laboratory Management, ASM Press, Washington, D. C.
Baselski, V.S., A.S. Weissfeld, and F. Sorrell. 2004. Approaches to billing laboratory services, pp. 567 - 573. In:
Garcia, L.S., V. S. Baselski, M. D. Burke, D. A. Schwab, D. L. Sewell, J. C. H. Steele, Jr., A. S. Weissfeld, D. S.
Wilkinson, and W. C. Winn, Jr. Clinical Laboratory Management, ASM Press, Washington, D. C.
Baselski, V.S., A.S. Weissfeld, and F. Sorrell. 2004. Charges and fees for laboratory services, pp. 574 - 579. In:
Garcia, L.S., V. S. Baselski, M. D. Burke, D. A. Schwab, D. L. Sewell, J. C. H. Steele, Jr., A. S. Weissfeld, D. S.
Wilkinson, and W. C. Winn, Jr. Clinical Laboratory Management, ASM Press, Washington, D. C.
Baselski, V.S., A.S. Weissfeld, and F. Sorrell. 2004. Rules and regulations in reimbursement, pp. 583 - 591. In:
Garcia, L.S., V. S. Baselski, M. D. Burke, D. A. Schwab, D. L. Sewell, J. C. H. Steele, Jr., A. S. Weissfeld, D. S.
Wilkinson, and W. C. Winn, Jr. Clinical Laboratory Management, ASM Press, Washington, D. C.
Baselski, V.S., A.S. Weissfeld, and F. Sorrell. 2004. Reimbursement compliance, pp. 592 - 602. In: Garcia, L.S.,
V. S. Baselski, M. D. Burke, D. A. Schwab, D. L. Sewell, J. C. H. Steele, Jr., A. S. Weissfeld, D. S. Wilkinson, and
W. C. Winn, Jr. Clinical Laboratory Management, ASM Press, Washington, D. C.
Baselski, V.S., A.S. Weissfeld, and F. Sorrell. 2004. Determination of profitability, pp. 603- 607. In: Garcia,
L.S., V. S. Baselski, M. D. Burke, D. A. Schwab, D. L. Sewell, J. C. H. Steele, Jr., A. S. Weissfeld, D. S. Wilkinson,
and W. C. Winn, Jr. Clinical Laboratory Management, ASM Press, Washington, D. C.
Moncada, J., J. Schachter, E. W. Hook III, D. Ferrero, C. Gaydos, T. C. Quinn, D. Willis, A. Weissfeld, D. H.
Martin. 2004. The effect of urine testing in evaluations of the sensitivity of the Gen-Probe Aptima Combo 2 assay
on endocervical swabs for Chlamydia trachomatis and Neisseria gonorrhoeae: the infected patient standard reduces
sensitivity of single site evaluation. Sex. Transm. Dis. 31:273-7.

Weissfeld, A.S. and V.S. Baselski. 2004. Introduction to procedure coding, reimbursement and billing compliance,
pp. 1.0.1 - 1.1.5 In: H. D. Isenberg (ed.), Clinical Microbiology Procedures Handbook, 2nd ed. ASM Press,
Washington, D.C.
Weissfeld, A. S. and V.S. Baselski. 2004. Procedure coding, reimbursement and billing compliance, pp. 1.2.1 -
1.2.10 In: H. D. Isenberg (ed.), Clinical Microbiology Procedures Handbook, 2nd ed. ASM Press, Washington, D.C.
Anderson, N. L., M. A. Noble, A. S. Weissfeld, and R. J. Zabransky. 2005. Cumitech 3B, Quality Systems in the
Clinical Microbiology Laboratory, Coordinating ed., D. L. Sewell. ASM Press, Washington, D.C.
Weissfeld, A. S., R. J. Halliday, D. E. Simmons, E. A. Trevino, P. H. Vance, C. M. O’Hara, E. G. Sowers, R.
Kern, R. D. Koy, K. Hodde, M. Bing, C. Lo, J. Gerrard, R. Vohra, and J. Harper. 2005. Photorhabdus
asymbiotica, a pathogen emerging on two continents that proves that there is no substitute for a well-trained clinical
microbiologist. J. Clin. Microbiol. 43:4152-4155.
Guest Lectureships and Addresses
1980
Automated susceptibility testing: Necessity or luxury?: Symposium on Antimicrobial Susceptibility Testing, Washington University, St. Louis, Missouri. Yersinia enterocolitica: Symposium on Laboratory Diagnosis of Bacterial Diarrhea, University of Wisconsin, Milwaukee, Wisconsin. Staphylococcus, Bacillus cereus and Clostridium perfringers: Symposium on Laboratory Diagnosis of Bacterial Diarrhea, University of Wisconsin, Milwaukee, Wisconsin. Alice S. Weissfeld – Page 12.
Yersinia enterocolitica: University of Connecticut Health Sciences Center, Farmington, Connecticut. Microbiological aspects of infection control in extended care setting: The Second Annual Symposium on Infection Control, The Greater St. Louis Infection Control Association, St. Louis, Missouri. Rapid methods in microbiology: California Association for Medical Laboratory Technology Winter Seminar, Los Angeles, California. Rapid methods in microbiology: California Association for Medical Laboratory Technology Annual Meeting, Anaheim, California. Newly described infectious diseases: California Association for Medical Laboratory Technology Annual Meeting, Anaheim, California. Coagulase-negative staphylococci: American Society for Medical Technology Annual Meeting, Los Angeles, California. Yersinia: American Society for Medical Technology Annual Meeting, Los Angeles, California. AIDS update: Los Robles Regional Medical Center, Thousand Oaks, California. Yersinia update: Bridgeport Hospital, Bridgeport, Connecticut. Laboratory approach and strategies to diagnosis of bacterial diarrhea: Southern California Branch of the American Society for Microbiology Annual Meeting, San Diego, California. Infections in immunocompromised patients: Southwestern Association of Clinical Microbiology Annual Meeting, Wichita, Kansas. The QC dilemma, where to start and how far to go: Southern California Branch of the American Society for Microbiology Annual Meeting, San Diego, California. Quality Management: Southwestern Association of Clinical Microbiology Annual Meeting, Fort Worth, Texas. Bioaerosol Contamination: Indoor Air Quality Seminar, Houston, Texas. The regulatory and legislative perspective for clinical microbiologists: STATENET - What is it? How do I get involved? American Society for Microbiology Annual Meeting, New Orleans, Louisiana. Interpretation of bioaerosol monitoring results and the role of potential laboratory accreditation. American Industrial Hygiene Conference and Exposition, New Orleans, Louisiana. Approaches to practical problems in clinical microbiology. American Society for Microbiology Annual Meeting, Atlanta, Georgia. Bacterial diarrhea: Southwestern Association of Clinical Microbiology, Houston, Texas. ASM and CLIA '88: Testimony before CLIAC, congressional meetings, and the White House Task Force on Health Care Reform: Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, Louisiana. Alice S. Weissfeld – Page 13.
Searching for MAC: Mycobacterium avium Seminar, San Juan, Puerto Rico. Laboratory Safety: American Society for Microbiology Teleconference Series. Medical Board Exams/Certification Issues. The Society of Armed Forces Medical Laboratory Scientists Annual Meeting, San Antonio, Texas. Update: Implementation of the Clinical Laboratory Improvement Act. American Society for Microbiology Annual Meeting, Washington, D.C. "Oohhh, Was It Something I Ate?!": Houston Society for Clinical Laboratory Scientist Meeting, Houston, Texas. Microbiological Aspects of Helicobacter pylori: Joint Meeting of the FDA Anti-Infective Drugs Advisory Committee (55th) and Gastrointestinal Drugs Advisory Committee, Gaithersburg, Maryland. Environmental Worms 'N Things: Southern California Branch of the American Society for Microbiology Annual Meeting, San Diego, California. Quality Assurance in Diagnostic Virology: 12th Annual Clinical Virology Symposium, Clearwater, Florida. Flexibility and the Business of Clinical Microbiology: American Society for Microbiology Annual Meeting, New Orleans Louisiana. Update: Implementation of the Clinical Laboratory Improvement Act. American Society for Microbiology Annual Meeting, New Orleans, Louisiana. How to Ensure that Microbiology Results Contribute to Quality Patient Care: Texas Society for Clinical Microbiology, Dallas, Texas. Challenge of the Environment: The Laboratory's Role in Investigating Illness Possibly Related to the Environment. American Society for Microbiology Annual Meeting, Miami Beach, Florida. CLIA in the 1990s: A Legislative and Regulatory Update. American Society for Microbiology Annual Meeting, Miami Beach, Florida. Assessment of Environmental Microbial Hazards. Southern Association for Clinical Microbiology, 25th Anniversary Meeting, Jackson, Mississippi. ASM PSAB Update on Legislative and Regulatory Issues. Southern Association for Clinical Microbiology, 25th Anniversary Meeting, Jackson, Mississippi. Can We Stop the Culture of Catheter Tips? South Central Association for Clinical Microbiology, Fall 1997 Meeting, Toledo, Ohio. Expanding Your Microbiology Services Workshop. South Central Association for Clinical Microbiology, Fall 1997 Meeting, Toledo, Ohio. Alice S. Weissfeld – Page 14.
Show Me the Money!: The Macro Future in Microbiology. Western New York Branch of the American Society for Microbiology Fall Meeting, Foundation for Microbiology Lecture Program, Buffalo, New York. Rapid Tests for Large and Small Laboratories. Northern California Branch of the American Society for Microbiology and the Northern California Association of Public Health Microbiologists Fall Meeting, Foundation for Microbiology Lecture Program, Concord, California. Two-day Professional Educational Course: Health Effects and Risk Assessment of Biological Contamination in Indoor Environment (A Clinical Approach to Environmental Issues), Sponsored by the World Health Organization and the Department of Health, National Centre for Occupational Health , South Africa. Course presented in Johannesburg, Durban, and Cape Town, South Africa. Show Me the Money!: A Macro Future in Clinical Microbiology. Foundation for Microbiology Lecture at the Joint Annual Meeting of the Missouri Branch of the American Society for Microbiology and the Midwest Microbiology Educators Conference, St. Louis, Missouri. Show Me the Money!: A Macro Future in Microbiology. Workshop at the Oregon Spring Seminar sponsored by The Oregon Association for Clinical Laboratory Science and The Oregon State Society of American Medical Technologists, Eugene, Oregon. Introduction and Definitions. Workshop 12, Financial issues in microbiology: From cost analysis and microeconomics to value analysis and microeconomics, American Society for Microbiology Annual Meeting, Chicago, Illinois. Financial Assessment of Microbiology Tests. Workshop 12, Financial issues in microbiology: From cost analysis and microeconomics to value analysis and microeconomics, American Society for Microbiology Annual Meeting, Chicago, Illinois. Financial Issues in Microbiology: How to Get Paid for What You Do and Not Break Any Laws. 23rd Annual Update in Clinical Immunology, Microbiology, and Infectious Diseases. The University of Utah School of Medicine, Park City, Utah. Introduction and Definitions. Workshop 1, Financial Issues in Microbiology: How to Get Paid for What You Do and Not Break Any Laws, American Society for Microbiology Annual Meeting, Los Angeles, California. Introduction to Compliance/OIG Document, Workshop 1, Financial Issues in Microbiology: How to Get Paid for What You Do and Not Break Any Laws, American Society for Microbiology Annual Meeting, Los Angeles, California. Clinical Laboratories as Critical Sentinals for a Bioterrorism Event, Panel Discussion #1 (Public Health as First Responders), National Bioterrorism Preparedness and Response Initiative, Regional Meeting, Denver, Colorado. Environmental Microbiology, Florida Association for Clinical Microbiology Conference 2000, Orlando, FL. CPT Codes, Compliance and More, Florida Association for Clinical Microbiology Conference 2000, Orlando, FL. Alice S. Weissfeld – Page 15.
Introduction and Background, Workshop 101-01, The ABCs of Reimbursement and Compliance: How to Cost, Code, Bill and Be Happy, American Society for Microbiology Annual Meeting, Orlando, Florida. Introduction to Compliance, Workshop 101-01, The ABCs of Reimbursement and Compliance: How to Cost, Code, Bill and Be Happy, American Society for Microbiology Annual Meeting, Orlando, Florida. Level A Bioterrorism Training for Laboratories, Houston, Texas. Introduction and Background, Workshop 102-01, The ABCs of Reimbursement and Compliance: How to Cost, Code, Bill and Be Happy – 2002 Edition, Annual Meeting of the American Society for Microbiology, Salt Lake City, Utah. Introduction to Compliance, Workshop 102-01, The ABCs of Reimbursement and Compliance: How to Cost, Code, Bill and Be Happy – 2002 Edition, Annual Meeting of the American Society for Microbiology, Salt Lake City, Utah. The Breadth of Opportunities Available to Microbiologists: How Microbiologists Make Their Living – Clinical Microbiology, Annual Meeting of the American Society for Microbiology, Salt Lake City, Utah. Reimbursement Issues for the Clinical Microbiology Laboratory, 17th Annual Symposium on Contemporary Topics in Clinical Microbiology and Infectious Disease, Syracuse, New York. Weapons of Mass Destruction – Biological Agents, Advanced HazMat Course, Texas A&M University Fire School, College Station, Texas. Weapons of Mass Destruction – Biological Agents, First on the Scene – Knowing Your ChemBio Hazards Course, Federal Bureau of Investigation and Harris County Sheriff’s Academy, Houston, Texas. Bioterrorism and the Clinical Microbiology Laboratory - Bioterrorism and Environmental Sampling Issues, Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, California. Introduction and Background, Workshop 103-10, Regulatory Update on Changes in Coding and Reimbursement, Annual Meeting of the American Society for Microbiology, Washington, DC. Quality Assurance in Clinical Microbiology. Southwestern Association of Clinical Microbiology Annual Meeting, Kansas City, MO. Billing and CPT Codes Workshop. Southwestern Association of Clinical Microbiology Annual Meeting, Kansas City, MO. A Quality Assurance Program for Microbiology, South Central Association of Clinical Microbiology Annual Meeting, Memphis, TN. Weapons of Mass Destruction - Biological Agents, Advanced HazMat Course, Texas A&M University. Review of Terminology, Rules and Regulations. Workshop 09 Regulatory Update on Changes in Coding and Reimbursement: Surviving and Thriving in a Hostile and Confusing Environment, Annual Meeting of the American Society for Microbiology, New Orleans, LA. Alice S. Weissfeld – Page 16.
Reimbursement and Compliance Issues for the Clinical Laboratory. Sunrise Symposium, Annual Meeting of the American Society for Microbiology, New Orleans, LA. Getting the Work Done! Clinical Microbiolgy Workforce Issues. Special Interest Session, Annual Meeting of the American Society for Microbiology, New Orleans, LA. What I Did for Love. The bioMérieux Sonnenwirth Award Lecture, Annual Meeting of the American Society for Microbiology, New Orleans, LA. What’s New in Infection Control. Houston Chapter-APIC, Houston, TX. Weapons of Mass Destruction - Biological Agents, Advanced HazMat Course, Texas A&M University Fire School, College Station, Texas Weapons of Mass Destruction – Biological Agents, Texas Medical Rangers, Houston, Texas Biological Weapons of Mass Destruction and Avian and Pandemic Influenza, Advanced HazMat Course, Texas A&M University Fire School, College Station, Texas Introduction to USP Chapters <795> and <797>, Alabama State Board of Pharmacy, Birmingham, Alabama. “Setting Up an Environmental Monitoring Program”; June 2006, APEx Kinetic Aseptic 3-Day Training Program, Compounding Sterile Preparations (Based on USP <797> and the NIOSH

Source: http://criticalpoint.info/wp-content/uploads/AliceWeissfeld_CV.pdf